Biotech · Public company · South San Francisco, CA, US
Assembly Biosciences, Inc.
Ticker ASMB · SEC CIK 0001426800
Track this companyFree. Adds Assembly Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline16
- ABI-H0731Phase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ABI-H2158Phase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Entecavir (ETV)Phase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- NrtIPhase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- SOC ETVPhase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- SOC NUCPhase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ABI-1179Phase 1 · Recurrent Genital Herpes Simplex Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- ABI-H2158 Reference FormulationPhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ABI-H2158 Test FormulationPhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ABI-M201Phase 1 · Ulcerative Colitis Chronic MildClinicalTrials.gov · fetched Nov 12, 2026
- EsomeprazolePhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Ethinyl Estradiol / LevonorgestrelPhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Vebicorvir (VBR)Phase 1 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesPHASE1 · COMPLETED · started Dec 8, 2024ClinicalTrials.gov NCT06698575 · fetched Nov 12, 2026
- A Study to Evaluate the Mass Balance Absorption and AME of VBRPHASE1 · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04637139 · fetched Nov 12, 2026
- A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase InhibitorsPHASE2 · TERMINATED · started Nov 11, 2020ClinicalTrials.gov NCT04454567 · fetched Nov 12, 2026
- A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus InfectionPHASE2 · TERMINATED · started Aug 28, 2020ClinicalTrials.gov NCT04398134 · fetched Nov 12, 2026
- A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy AdultsPHASE1 · COMPLETED · started Oct 18, 2019ClinicalTrials.gov NCT04142762 · fetched Nov 12, 2026
- A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy AdultsPHASE1 · COMPLETED · started Sep 6, 2019ClinicalTrials.gov NCT04083716 · fetched Nov 12, 2026
- ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative ColitisPHASE1 · TERMINATED · started Jun 24, 2019ClinicalTrials.gov NCT03923478 · fetched Nov 12, 2026
- A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B PatientsPHASE2 · TERMINATED · started Dec 20, 2018ClinicalTrials.gov NCT03780543 · fetched Nov 12, 2026
- A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis BPHASE1 · COMPLETED · started Nov 13, 2018ClinicalTrials.gov NCT03714152 · fetched Nov 12, 2026
- A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)PHASE2 · COMPLETED · started Jun 19, 2018ClinicalTrials.gov NCT03577171 · fetched Nov 12, 2026
- A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B InfectionPHASE2 · COMPLETED · started Jun 11, 2018ClinicalTrials.gov NCT03576066 · fetched Nov 12, 2026
SEC filings12
- 8-K/A · 8-K/ASEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 8, 2025 · fetched Nov 12, 2026